Azarga (brinzolamide 1%/timolol 0.5% eye drops suspension; Alcon) and Cosopt (dorzolamide 2%/timolol 0.5% eye drops solution; Merck) are equally efficacious in IOP-lowering capacity, however, Azarga offers greater ocular comfort, according to a study presented at this week?s European Glaucoma Society congress in Berlin, Germany.
Increased fruit and vegetable consumption reduces the risk of glaucoma, according to a study reported in the June 2008 issue of the American Journal of Ophthalmology.
The diuretic agents, vasopressin-receptor antagonists, or vaptans, may have a use in the treatment of glaucoma, according to a study appearing in the 10 May, 2008 issue of The Lancet.
Avastin (bevacizumab) does not exert any toxic effects on the retina and its function, according to a study published in the January issue of Retina journal.
Delaying treatment in patients with subfoveal neovascular age-related macular degeneration (wet AMD) correlates to progressive and substantial loss of visual acuity (VA), according to a report published online ahead of print by Eye.
The OPTTX System (Novadaq Technologies) stabilizes or improves vision at one year in patients with wet age-related macular degeneration (AMD), many of who have failed previous therapies and have no other treatment alternatives, according to Professor Giovanni Staurenghi of Sacco Hospital, University of Milan, Italy, reporting at this year?s EURETINA congress in Vienna, Austria.
Anaesthesia administered by sharp needles carries a greater risk of serious complications than subtenons cannula administration, according to a study published online ahead of print in Eye.
Posterior keratocyte density measurements could be a means of following eyes with post-LASIK ectasia, according to study results presented at this year's meeting of the American Academy of Ophthalmology (AAO).
The month in which one is born may increase the likelihood of suffering severe myopia, according to a study published in the April 2008 issue of Ophthalmology.
It is widely accepted, anecdotally, that long-term exposure to television and computer screens causes a reaction in the eyes; namely, blurred vision, redness and dry eye symptoms. But is this a condition that is worthy of its own name?
With the development of new instruments that accurately and easily measure tear osmolarity, the authors believe that this test should become the 'gold standard' for diagnosing dry eye disease in both the routine clinical and research settings.
Attempts to control IOP through medical therapy tend to be first-line treatment although patient compliance and ocular surface integrity remain a concern
The psychological outlook of patients has an enormous influence on their perception of quality of life after cataract surgery, even if the visual outcome is poor.
Fill in OTE's online readership survey for the chance to win €500 Marriott hotel vouchers.
A proprietary miniature glaucoma device (Ex-PRESS; Optonol Ltd.) implanted under a partial-thickness scleral flap achieves significant decreases in intraocular pressure (IOP) in patients with glaucoma, according to Peter A. Netland, MD, PhD, reporting at the 2007 meeting of the Association for Research in Vision and Ophthalmology.
Organizers of the first-ever World Glaucoma Day are calling the international effort a success, with "amazing achievements" that helped raise awareness about the dangers of glaucoma and the need for screenings and treatment.
A 2006/2007 survey gauged the opinions and practice styles of 1 093 ophthalmologists in France. Here are the results.
The World Glaucoma Day inspired glaucoma specialists around the world to rally local support in order to undertake an enormous task: to reduce the number of people who are unnecessarily going blind from a treatable condition.
The current gold standard for measuring intraocular pressure (IOP), the Goldmann tonometer (GAT), has considerable flaws. Dr Goldmann designed his tonometer to provide accurate measurements in eyes with average corneas, but we now know that many corneas vary significantly from the "average".
It is clear that the previously underappreciated condition of dry eye disease should now be regarded as a serious public health problem that is worthy of diagnosis and effective treatment.
The medical treatment of glaucoma is limited by patient adherence to medications. By the end of a year, approximately half of patients are not refilling their medications as directed, and physicians are not able to tell those who are from those who are not.
Studies have demonstrated that SLT is a safe and effective means of treatment, and comparable in these respects to ALT, but how does SLT fare against ALT in the long-term? It was our mission to establish this.
Corneas from donors up to the age of 75 are suitable for transplantation, according to a study published in the April 2008 issue of Ophthalmology.
Martine J. Jager, MD, PhD, outgoing president of the Association for Research in Vision and Ophthalmology (ARVO), called for greater international expansion and involvement during her keynote speech at this year's meeting.
The inadequate refrigeration of chloramphenicol generics in India could be contributing to the evolution of resistant organisms and impacting the quality of Indian-made products available in Europe, according to a study published in the May 2008 issue of the British Journal of Ophthalmology.
Table 2: Additional interventions required during follow-up.
News In Focus for June 2008
Table 1: Mean IOP over time.
Selective Laser Trabeculoplasty (SLT) has been used for over 10 years to lower intraocular pressure (IOP) in patients with open angle glaucoma (OAG) as well as ocular hypertension (OHT). Studies have demonstrated that SLT is a safe and effective means of treatment, and comparable in these respects to Argon Laser Trabeculoplasty (ALT), but how does SLT fare against ALT in the long-term? It was our mission to establish this.
On April 28, a meeting of the FDA Ophthalmic Devices Panel confirmed that a study investigating patient satisfaction and quality of life post-LASIK is to be conducted in the US by a Joint LASIK Study Task Force.
